Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

DVAX

DVAX News

Newswire

22:46

Vaxart Extends Cash Runway into Q2 2027 with Dynavax Partnership, Aims for 2026 Data Readouts

05:22

Dynavax Technologies Surpasses Q3 Earnings Estimates by 50%, Misses Revenue Expectations by 0.23%

22:39

Dynavax Aims for 60% U.S. Hepatitis B Market Share by 2030 Amid New COVID-19 Vaccine Deal and Expanded Share Repurchase

16:21

Dynavax Technologies Reports Q3 Earnings of $26.9 Million and Revenue of $94.9 Million

02:13

Dynavax Technologies: A Fair Value Assessment

View More

About DVAX

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More